Comparative Analysis of Clinical Profile of Patients Admitted with Idiopathic Dilated Cardiomyopathy in a Tertiary Care Hospital
Conclusion: In our study, treatment with the medications significantly improved EF and LVES. However, there was no treatment-based difference in the patients on ACE inhibitors or ARBs in the improvement in EF. Our study also observed significance difference in platelets count, SGOT, SGPT, and LDL levels in idiopathic DCM patients when compared with healthy controls.Keywords:ACE Inhibitors,ARBs,DCM,LVEF,LVES,NYHA ClassView:PDF (149.48 KB)Click here to download the PDF file.‹ J. Cardiovasc. Dis. Res., 8(2), 2017Effect of Nebivolol on Endothelial Dysfunction in Coronary Artery Disease Patients -An Open Label Randomized Controlled Clinical Trial (NEDCAD) ›
Source: Journal of Cardiovascular Disease Research - Category: Cardiology Authors: yunus Source Type: research
More News: Beta-Blockers | Cardiology | Cardiomyopathy | Cardiovascular | Clinical Trials | Dilated Cardiomyopathy | Education | Furosemide | Graduation | Heart | Heart Failure | Hypertension | India Health | Spironolactone | Study | Universities & Medical Training